.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC17_Tirofiban.Tirofiban .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC17_Tirofiban.Tirofiban| name: | Tirofiban | |
| ATC code: | B01AC17 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 25 | mg |
| volume of distribution: | 30 | L |
| clearance: | 213 | mL/min |
| other parameters in model implementation | ||
Tirofiban is a non-peptide, reversible inhibitor of the glycoprotein IIb/IIIa receptor on platelets, used as an antiplatelet agent to reduce thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) and during percutaneous coronary intervention (PCI). It is approved and in clinical use today.
Pharmacokinetic parameters in healthy adult volunteers after intravenous administration.